Foghorn Therapeutics Inc. Common Stock

FHTX XNAS • PHARMACEUTICAL PREPARATIONS

Historical Short Interest Share

Chase Ink Business Preferred®

Earn Up to 150K Bonus Points

Transfer points to 14+ airline & hotel partners. Up to 40% upgrade value on first class travel. $95/yr.

Apply Now

Market Cap

210M

Short interest (May 15)

2.3%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.56%

↑ 20.3%

Available Shares

300K

↑ 62.4%

Price Chart

Company Overview

Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.

Company Info

Exchange: NASDAQ

Industry: PHARMACEUTICAL PREPARATIONS

CIK: 0001822462

Asset Type: CS

Market Data

Market Cap: $213,131,536

Employees: 106

Status: Active

Short Interest

Current Borrow Fee 0.56%

Range: 0.34% - 1.11%

Available Shares 300K

Range: 150K - 250K

Recent Changes

Fee Change: ↑ 23.6%

Available Change: ↓ 69.2%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime